Cyclic peptide modulators of fcrn and uses thereof
TW202641818APending Publication Date: 2026-10-16COVANT THERAPEUTICS OPERATING INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114145663
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-09-30
- Filing Date
- 2025-11-21
- Publication Date
- 2026-10-16
Abstract
Provided herein are cyclic peptides capable of binding to and inhibiting neonatal fragment crystallizable receptor (FcRn) proteins, and methods of using the same for the treatment and / or prevention of various diseases, including conditions associated with FcRn activity and / or immunoglobulin G (IgG) autoantibody levels in a subject.
Need to check novelty before this filing date? Find Prior Art